Healthcare Industry News: Novation
News Release - March 27, 2007
Novation Signs New Technology Agreement With IRadimed
Agreement Offers Latest MR-Compatible Infusion System to HospitalsIRVING, TX--(Healthcare Sales & Marketing Network)--Mar 27, 2007 -- Novation, the health care contracting services company of VHA Inc., and the University HealthSystem Consortium (UHC), two national health care alliances, has signed a single-source, new technology agreement with IRadimed for its MRidium(TM) MRI Infusion System.
The agreement is effective now through August 31, 2009. The agreement was awarded through Novation's new technology evaluation process, which accelerates the review process so new and improved technologies do not have to wait for a scheduled competitive bid. The process allows VHA and UHC members speedier access to savings on the latest FDA approved medical technology.
The MRidium(TM) MRI Infusion pump is the only magnetic resonance-compatible infusion pump with 3 Tesla clearance at 10,000 gauss-line, which means it can be used in close proximity to the MR equipment without interference.
About Novation
Based in Irving, Texas, Novation is the leading health care contracting services company, delivering unmatched savings and value to nearly 2,500 members of VHA Inc. and the University Health System Consortium (UHC), two national health care alliances. Through its competitive bid process, Novation develops and manages contracts with more than 500 suppliers, both large and small. By combining scale and agility with clinical knowledge and product expertise, Novation offers the most extensive range of innovative contracting services, including: contract development, contract and supplier management, custom contracting, enhanced savings programs, online contract management and analytical tools, order management and online supplier connectivity. VHA and UHC members used Novation's contracts to purchase more than $25 billion in supplies in 2005.
Source: Novation
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
